If you are confused about the recommendations made by different professional groups for the COVID-19 pandemic, you’ve come to the right place. Before you continue to read this rather long article, let’s start with the end in mind and begin with the conclusion that you may have been told. There is no early treatment for…
Tag: Covid-19
One Day MD reports “Dr Richard Bartlett Inhaled Budesonide Protocol for COVID-19”
In April 2021, The Lancet reported evidence of UK’s first effective drug to treat COVID-19 in patients at home, inhaled budesonide, showing the treatment can reduce recovery time by a median of three days. The treatment has since been included in clinical guidelines for treating early-stage COVID-19 across the UK, Canada and India. Dr. Richard Bartlett shared…
Trial Site News reports “Ivermectin: Pros vs Cons. Dr. Luis Garegnani and Dr. Pierre Kory Debate The Issue”
Dr. Luis Garegnani from Argentia wrote an opinion piece on Ivermectin not having enough evidence behind it in BMJ Journals. Dr. Pierre Kory of the FLCCC disagrees. Both doctors debate this issue with Dr. Erin Stair as the moderator. About Luis Garegnani: Luis Garegnani is a Professor of Research methods and evidence-based medicine at Instituto…
Open Forum Infectious Disease reports “Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection”
Ivermectin is an antiparasitic drug being investigated for repurposing against SARS-CoV-2. Ivermectin showed in-vitro activity against SARS-COV-2 at high concentrations. This meta-analysis investigated ivermectin in 24 randomized clinical trials (3328 patients) identified through systematic searches of PUBMED, EMBASE, MedRxiv and trial registries. Ivermectin was associated with reduced inflammatory markers (C-Reactive Protein, d-dimer and ferritin) and…
Research Square reports “Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic”
Up-to-date, there is no recognized effective treatment or vaccine for the treatment of COVID-19 that emphasize urgency around distinctive effective therapies. This study aims to evaluate the anti-parasitic medication efficacy “Ivermectin” plus standard care ((Azithromycin, vitamin C, Zinc, Lactoferrin & Acetylcystein & prophylactic or therapeutic anticoagulation if D-dimer > 1000)) in the treatment of mild/moderate and severely…
Cell Reports Medicine reports “Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells”
Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of >200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers…
FLCCC reports “The WHO’s Denial of Ivermectin: Big Science, Disinformation and their Impacts on Human Rights”
“The WHO is completely compromised,” says Dr. Kory. “They are protecting other interests.” The scale of the markets (think vaccines and pharmaceutical companies) that would be affected by the approval of ivermectin for the prevention and treatment of COVID-19 is massive. Meanwhile, because the WHO failed to recommend ivermectin for worldwide use, hundreds of thousands…
Gateway Pundit reports “U.S. Intelligence Community Already Knows that Covid Came from the Chinese Bio Lab”
Why did the Biden Administration suddenly reverse course and order the U.S. intelligence community to “investigate the origins of the Covid-19 pandemic?” Especially doing this policy backflip less than 24 hours after White House spokeswoman Jen Psaki insisted that any investigation should be done an international organization. It can only mean one thing–new intelligence has…
Organic Consumers Association reports “The Vaccine Passport Dilemma: How the Vaccine Passport Exacerbates Existing Inequalities In Society”
During the pandemic, the government public health institutions promised us solutions that failed to meet expectations. Based on faulty Imperial College models, we were promised lockdowns as a short-term solution that would contain the pandemic.We were promised that mask mandates would stop COVID-19 despite their ambiguous evidence for efficacy and the later evidence that showed less than promised benefits. Now we are…
Mercola reports “More Good News on Ivermectin”
Ivermectin is an antiparasitic drug that may be even more useful against COVID-19 than hydroxychloroquine (HCQ). However, like HCQ, use of ivermectin has been globally suppressed, discouraged and even warned against, despite decades of safe use for other ailments In the U.S., the Frontline COVID-19 Critical Care Alliance (FLCCC) has been calling for widespread adoption…